AbbVie ends deal for Infinity's duvelisib

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) said AbbVie Inc. (NYSE:ABBV) ended the companies' 2014 deal

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE